Citius Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Citius Pharmaceuticals

11/08/2022 23:39

* Citius Pharmaceuticals Inc  CTXR.OQ  reported a quarterly
adjusted loss of 6 cents​​ per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of 5 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Citius Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 6 cents​.
    * The mean earnings estimate of analysts had risen by
about 33.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Citius Pharmaceuticals Inc shares had risen by 14.1% this
quarter and lost 31.8% so far this year.
    * The company reported a quarterly loss of $8.86 million.
    * Wall Street's median 12-month price target for Citius
Pharmaceuticals Inc is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 11
at 10:39 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.05          -0.06          Missed
 Mar. 31 2022      -0.07          -0.05          Beat
 Dec. 31 2021      -0.06          -0.06          Met
 Sep. 30 2021      -0.04          -0.02          Beat